GenVec, Inc. (Nasdaq: GNVC) $0.80. Today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to TNFerade for the treatment of pancreatic cancer.

What They Do: GenVec, Inc. is a biopharmaceutical company developing novel therapeutic drugs and vaccines.

Almost Family, Inc. (Nasdaq: AFAM) $31.64. Today announced its financial results for the three months ended September 30, 2009. Net service revenues increased 31% to $76.3 million.